心血管植入型电子器械术后随访的专家共识(2020)

2020-12-30 中华医学会心电生理和起搏分会 中华心律失常学杂志.2020.24(6):532-544.

心血管植入型电子器械(CIED)主要用于心动过缓、心动过速和心力衰竭的诊断、监测和治疗。对已接受CIED 治疗的患者进行定期随访是CIED 治疗过程中的重要环节。通过随访可了解CIED 治疗的效果,及

中文标题:

心血管植入型电子器械术后随访的专家共识(2020)

发布日期:

2020-12-30

简要介绍:

心血管植入型电子器械(CIED)主要用于心动过缓、心动过速和心力衰竭的诊断、监测和治疗。对已接受CIED 治疗的患者进行定期随访是CIED 治疗过程中的重要环节。通过随访可了解CIED 治疗的效果,及时发现和处理手术及CIED 本身可能出现的并发症及故障,了解CIED 是否处于最佳工作状态,使患者得到最优治疗获益。因患者植入CIED 类型不同,其随访目的、频度、方式和内容均有所不同。随访方式包括诊室随访和远程随访,但远程随访的患者,仍建议每年至少1 次诊室随访。常规起搏器患者建议选择合适的起搏方式并优化参数,以满足患者不同的需求。植入型心律转复除颤器(ICD)患者,建议程控合适的心动过速识别参数和治疗参数,以减少ICD 电击治疗。对于心脏再同步治疗(CRT)患者,则需要优化再同步参数,保证高比例的再同步起搏,以提高CRT 反应性。希氏- 浦肯野系统(希浦系统)起搏参与的CIED 患者的随访和程控,需要专门人员经过培训合格后方能胜任。而对于植入型心电事件记录仪(ICM)患者的随访,建议设置合理的感知和监测参数,并根据随访检出事件结果来决定其后续的诊疗措施。所有开展CIED 治疗的医院均应建立规范的CIED 资料的登记和管理制度。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1008021, encodeId=18f710080215d, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91755573460, createdName=ms9000000234913804, createdTime=Sun Aug 15 10:41:02 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967603, encodeId=540896e60371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b35505844, createdName=ms3000002072272788, createdTime=Fri May 21 21:02:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949513, encodeId=a6c994951367, content=棒,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/6c68a372854f41b5adb49f135b753d9d/1a1eb9a2fcda4ae6a56dc5fb7bacdb20.jpg, createdBy=47355464648, createdName=鳌拜拜, createdTime=Fri Mar 19 15:47:46 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920527, encodeId=f04792052ee7, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:53 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920526, encodeId=139392052618, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:50 CST 2021, time=2021-01-28, status=1, ipAttribution=)]
    2021-08-15 ms9000000234913804

    学到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1008021, encodeId=18f710080215d, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91755573460, createdName=ms9000000234913804, createdTime=Sun Aug 15 10:41:02 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967603, encodeId=540896e60371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b35505844, createdName=ms3000002072272788, createdTime=Fri May 21 21:02:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949513, encodeId=a6c994951367, content=棒,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/6c68a372854f41b5adb49f135b753d9d/1a1eb9a2fcda4ae6a56dc5fb7bacdb20.jpg, createdBy=47355464648, createdName=鳌拜拜, createdTime=Fri Mar 19 15:47:46 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920527, encodeId=f04792052ee7, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:53 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920526, encodeId=139392052618, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:50 CST 2021, time=2021-01-28, status=1, ipAttribution=)]
    2021-05-21 ms3000002072272788

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1008021, encodeId=18f710080215d, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91755573460, createdName=ms9000000234913804, createdTime=Sun Aug 15 10:41:02 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967603, encodeId=540896e60371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b35505844, createdName=ms3000002072272788, createdTime=Fri May 21 21:02:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949513, encodeId=a6c994951367, content=棒,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/6c68a372854f41b5adb49f135b753d9d/1a1eb9a2fcda4ae6a56dc5fb7bacdb20.jpg, createdBy=47355464648, createdName=鳌拜拜, createdTime=Fri Mar 19 15:47:46 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920527, encodeId=f04792052ee7, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:53 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920526, encodeId=139392052618, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:50 CST 2021, time=2021-01-28, status=1, ipAttribution=)]
    2021-03-19 鳌拜拜

    棒,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1008021, encodeId=18f710080215d, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91755573460, createdName=ms9000000234913804, createdTime=Sun Aug 15 10:41:02 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967603, encodeId=540896e60371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b35505844, createdName=ms3000002072272788, createdTime=Fri May 21 21:02:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949513, encodeId=a6c994951367, content=棒,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/6c68a372854f41b5adb49f135b753d9d/1a1eb9a2fcda4ae6a56dc5fb7bacdb20.jpg, createdBy=47355464648, createdName=鳌拜拜, createdTime=Fri Mar 19 15:47:46 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920527, encodeId=f04792052ee7, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:53 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920526, encodeId=139392052618, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:50 CST 2021, time=2021-01-28, status=1, ipAttribution=)]
    2021-01-28 14643f34m67暂无昵称

    学习好资料!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1008021, encodeId=18f710080215d, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91755573460, createdName=ms9000000234913804, createdTime=Sun Aug 15 10:41:02 CST 2021, time=2021-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967603, encodeId=540896e60371, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b35505844, createdName=ms3000002072272788, createdTime=Fri May 21 21:02:25 CST 2021, time=2021-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949513, encodeId=a6c994951367, content=棒,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210302/6c68a372854f41b5adb49f135b753d9d/1a1eb9a2fcda4ae6a56dc5fb7bacdb20.jpg, createdBy=47355464648, createdName=鳌拜拜, createdTime=Fri Mar 19 15:47:46 CST 2021, time=2021-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920527, encodeId=f04792052ee7, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:53 CST 2021, time=2021-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920526, encodeId=139392052618, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Jan 28 08:25:50 CST 2021, time=2021-01-28, status=1, ipAttribution=)]
    2021-01-28 14643f34m67暂无昵称

    学习好资料!

    0

拓展阅读

心血管疾病营养处方专家共识

中国康复医学会心血管病专业委员会 · 2014-02-01

2014 英国学会联合会心血管疾病预防推荐意见(JBS3)

英国学会联合会(JBS,Joint British Societies) · 2014-03-26

2014 ESC/EACVI立场声明:临床实践中心血管影像学检查的适宜性应用标准

欧洲心脏病学会(ESC,European Society of Cardiology) · 2014-05-20

2014 AHA科学报告:在美国西班牙裔/拉丁裔人群中心血管疾病和中风的状态

美国心脏协会(AHA,American Heart Association) · 2014-07-14

2014 ACC/AHA非心脏手术患者围术期心血管的评估和管理指南

美国心脏病学会(ACC,American College of Cardiology) · 2014-08-01